U.S. healthcare affordability – The Milli Chronicle

Friday, October 17, 2025

Latest:

French Prime Minister Lecornu Secures Confidence Votes, Paving Way for Constructive Budget Reforms
China Expands Green Aviation Exports with New Biofuel Approvals
Global Banking Sector Shows Strength Amid Market Adjustments and Renewed Investor Focus on Long-Term Stability
U.S. Expands Counter-Narcotics Operations in the Caribbean with Renewed Focus on Regional Security and Cooperation
Pharma Giants Lead the Way in Affordable, Direct-to-Consumer Healthcare Transformation

Factual Version of a Story

Latest News World

NewsDesk Milli Chronicle October 17, 2025October 17, 2025 affordable medicines, American drug cost reduction, AstraZeneca discounts, Bristol-Myers Squibb price cuts, direct-to-consumer drug sales, drug price reform, Eli Lilly Zepbound online sales, Merck fertility treatment discounts, Novo Nordisk Ozempic Wegovy offers, patient-first healthcare model, Pfizer Medicaid drug pricing deal, pharma industry transformation, pharmaceutical innovation, reduced prescription drug prices, Sanofi insulin price cap, telehealth partnerships, Trump administration healthcare initiatives, TrumpRx.gov launch, U.S. healthcare affordability, U.S. pharmaceutical companies, Washington healthcare news, women’s telehealth provider Wisp, Zealand Pharma direct-to-patient model

Pharma Giants Lead the Way in Affordable, Direct-to-Consumer Healthcare Transformation

Washington – In a major move set to reshape the U.S. healthcare industry, several global pharmaceutical companies have announced direct-to-consumer

Featured News World

NewsDesk Milli Chronicle October 1, 2025October 1, 2025 healthcare policy news, international drug pricing standards, Medicaid drug price cuts, Pfizer CEO Albert Bourla, Pfizer drug prices, Pfizer global pricing, Pfizer lowers drug prices, Pfizer pharmaceutical news, Pfizer shares surge, Pfizer White House agreement, pharmaceutical industry reforms, prescription drug price reform, Trump administration healthcare deal, Trump administration pharma deal, Trump healthcare policy, TrumpRx platform, U.S. drug pricing reform, U.S. healthcare affordability, U.S. prescription drug costs, White House healthcare initiative

Pfizer Strikes Landmark Deal With Trump Administration to Lower Drug Prices

In a move hailed as a turning point for U.S. healthcare, Pfizer agrees to align drug prices with global standards